Precision Medicine Group
Mark Clein is a highly experienced professional who currently serves as the Co-Founder & Chief Executive Officer at Precision Medicine Group. Prior to this, Mark held various leadership roles at companies such as United BioSource Corporation and US Bioservices. Mark holds an MBA in Finance from Columbia Business School and a BA in History from the University of North Carolina at Chapel Hill.
Precision Medicine Group
3 followers
Formed in 2012, Precision Medicine Group is a specialized services company supporting next-generation approaches to drug development and commercialization. Precision provides an integrated infrastructure that supports pharmaceutical and life sciences companies as they develop new products in the age of precision medicine. The company is headquartered in Bethesda, Md., with offices throughout the US, Canada, and Europe. For more information, visit precisionmedicinegrp.com.